Provider of medical and clinical services. The company offers research and development services for therapeutics, it manages clinical work for VAL 201, a peptide for the treatment of refractory prostate cancer.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore ValiRx Finland‘s full profile, request access.
© 2021 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.